Areteia Therapeutics introduces dexpramipexole, a novel oral drug in Phase 3 trials for asthma and COPD, aiming for approval ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Swoop has taken control of more than 60 patient communities by acquiring MyHealthTeam, positioning the Real ... specific communities such as “My Asthma Team” and “My Obesity Team.” ...

Obstructive pulmonary diseases are common in the elderly but often remain underdiagnosed due to limited spirometry availability or challenges with patient cooperation during testing. This study ...

We sought to better understand the mechanisms behind severe asthma so that we can better treat these patients." Roma Sehmi, senior and corresponding author of the paper and professor, Department ...

For 40 years, this leading nonprofit has advanced the patient voice and promoted patient-centered asthma and allergy care nationwide. To celebrate the milestone, Allergy & Asthma Network is ...